Therapeutic Efficacy Evaluation of Radioimmunotherapy With 90 Y-Labeled Anti-Podoplanin Antibody NZ-12 for Mesothelioma
Cancer Science - United States
doi 10.1111/cas.13979
Full Text
Open PDFAbstract
Available in full text
Date
March 12, 2019
Authors
Publisher
Wiley